Lexpos News

Local pharmacy leaders from across the country met to discuss critical issues and consider ways to secure community pharmacy’s place in plans to develop the health service. The Annual Conference of LPC Representatives held last week considered important topics for the coming year with speakers sharing insights on the 10 Year Health Plan, healthcare networks, [...]

The post LPC Conference plans pharmacy’s path in NHS transformation appeared first on Community Pharmacy England.

The following price concessions granted in November 2025 have rolled over to December 2025: Drug Pack size November 2025 price concession Carbocisteine 375mg capsules 120 £2.95 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide 1mg tablets 90 £31.73 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to [...]

The post Rolled over price concessions for December 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (03/12/2025) confirmed the following final list of price concessions for November 2025. Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.99 Aripiprazole 2.5mg tablets 28 £31.14 Carbocisteine 375mg capsules 120 £2.95 Estriol 0.01% vaginal cream with applicator 1 £47.05 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide [...]

The post November 2025 Price Concessions – Final Update appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid [...]

The post Funding & Reimbursement Shorts: Disallowed items appeared first on Community Pharmacy England.

Update 08/01/2026: Alzest transdermal patches (Dr Reddy’s Laboratories (UK) Ltd) in all strengths have been discontinued. Please note: Care is needed if switching between daily and twice weekly (Zeyzelf) rivastigmine patches to avoid the risk of dosing error. The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: [...]

The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches appeared first on Community Pharmacy England.